Andrew Chan, Ph.D., is an experienced scientist specializing in protein chemistry and metabolic engineering, currently holding positions as Scientist II at ElevateBio and Life Edit Therapeutics since March 2022. Prior experience includes roles as a Scientist at DMC Biotechnologies, Inc. and Postdoctoral Research Fellow at McMaster University. Andrew has a strong background in biochemical techniques and has investigated various topics, including the mechanism of action of the antibiotic holomycin and the magnetic navigation of loggerhead sea turtle hatchlings. Educational achievements include a Ph.D. in Biological Chemistry from the University of North Carolina at Chapel Hill and a Bachelor of Science in Biology from the same institution.